Tianjin, China

Xiuping Shen

This inventor holds 1 USPTO granted patent. Top assignee: Tasly Pharmaceutical Group Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiuping Shen. Retrieved from https://idiyas.com/inventor/xiuping-shen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xiuping Shen

Introduction

Xiuping Shen is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hepatic fibrosis. His innovative approach has led to the development of a unique patent that showcases his expertise and dedication to medical advancements.

Latest Patents

One of Xiuping Shen's key patents is titled "Use of radix salviae miltiorrhizae (danshen) or its preparations in preparation of drugs for treating diseases related to hepatic fibrosis." This invention focuses on the use of Radix Salviae Miltiorrhizae, commonly known as Danshen, in creating effective drugs for addressing hepatic fibrosis. This patent highlights his commitment to improving health outcomes through innovative drug development. He holds 1 patent in this area.

Career Highlights

Xiuping Shen is associated with Tasly Pharmaceutical Group Co., Ltd., a prominent company in the pharmaceutical industry. His work at Tasly has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medical research and innovation.

Collaborations

Some of his notable coworkers include Yonghong Zhu and Jinfang Hu. Their collaborative efforts have likely played a role in advancing the research and development of new pharmaceutical solutions.

Conclusion

In summary, Xiuping Shen is a distinguished inventor whose work in the pharmaceutical sector has led to significant advancements in the treatment of hepatic fibrosis. His innovative patent and collaboration with esteemed colleagues underscore his impact on the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…